Longer treatment with Tamoxifen reduces risks of cancer recurrence

Friday, March 25th, 2011

New research has found that a 5-year course of the breast cancer drug Tamoxifen works better than a 2-year course of the drug. The study, the results of which were published online in the Journal of Clinical Oncology, was conducted by scientists at the Cancer Research UK. The results have once again pointed out the […]

Cognitive Function Is Superior In Breast Cancer Patients Treated With Letrozole Versus Tamoxifen

Friday, July 17th, 2009

Source: Medical News Today New results show that postmenopausal women with breast cancer receiving adjuvant letrozole have better cognitive function than women being treated with tamoxifen. The data, from a recent meeting of the American Society of Clinical Oncology (ASCO), are drawn from a sub-study of the Breast International Group (BIG) 1-98 trial. The trial, […]